Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

MLA

Uros Markovic, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e73cda7ca683b5a149cef7fde21a9684&authtype=sso&custid=ns315887.

APA

Uros Markovic, Melania Carlisi, Vittorio Del Fabro, Emilia Cotzia, Clotilde Cangialosi, Anxur Merenda, Bruno Garibaldi, Valeria Calafiore, Francesco Acquaviva, Marina Parisi, Alessandra Romano, Renato Scalone, Salvatore Leotta, Santo Neri, Massimo Poidomani, Concetta Conticello, Giuseppe Sapienza, Donato Mannina, Vanessa Innao, … Giuseppina Uccello. (2019). Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.

Chicago

Uros Markovic, Melania Carlisi, Vittorio Del Fabro, Emilia Cotzia, Clotilde Cangialosi, Anxur Merenda, Bruno Garibaldi, et al. 2019. “Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e73cda7ca683b5a149cef7fde21a9684&authtype=sso&custid=ns315887.